|This Slide: #34 of 100|
Slide #34. McKesson Corporation — Celesio
McKesson Corporation (NYSE:MCK)
McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, confirmed today that it has completed the previously announced agreement with Franz Haniel & Cie. GmbH to acquire their entire holding of Celesio shares. McKesson also confirmed it has completed the previously announced agreement with an affiliate of Elliott Management to acquire Celesio convertible bonds. McKesson now exceeds 75% ownership of Celesio shares on a fully diluted basis.
McKesson is engaged in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. Co.'s segments include: U.S. Pharmaceutical, which distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs; International, which provides distribution and services to wholesale, institutional, and retail customers; Medical-Surgical Solutions, which provides medical-surgical supply distribution, logistics, and other services to healthcare providers; and Prescription Technology Solutions, which brings together CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation.
McKesson SEC Filing Email Alerts Service
Open the MCK Page at The Online Investor »
Free MCK Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Strong Buy (3.59 out of 4)